21 European metropolitan areas emerge as final contenders in Bloomberg Philanthropies’ Mayors Challenge Bloomberg Philanthropies today revealed the 21 European metropolitan areas which have emerged as final contenders in its 2013-2014 Mayors Challenge, a competition to inspire metropolitan areas to generate innovative ideas that solve main challenges and improve city life, and that can spread to other cities ultimately. The finalists' proposed solutions address some of Europe's most critical issue areas: youth unemployment, aging populations, civic engagement, economic development, environment and energy concerns, public health and safety, and making government more efficient.Blood biomarkers are regarded as important and important companion now tests in assessing any fresh or approved therapy. Potentially, new tumor biomarkers could possibly be used to develop efficient new blood exams for monitoring cancer, related to blood glucose exams used to monitor diabetes, or the high sensitivity C-reactive protein test for heart disease, Dr. Hoon described. His department is regarded internationally for discovering genetic and epigenetic biomarkers for various kinds of solid tumor cancers. The Abraxis grant covers several novel methods for identifying new malignancy biomarkers. In the initial phase, investigators shall search for protein biomarkers in prostate and breast cancer tissues. Hoon described. The new Abraxis financing will support the search for new epigenetic biomarkers for also pancreatic and liver tumor.